Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong · Delayed Price · Currency is HKD 7.73
-0.08 (-0.96%)
Aug 21, 2026, 4:08 PM HKT
Medlive Technology Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medlive Technology stock has a consensus rating of "Strong Buy" and an average price target of $12.64. The average 1-year stock price forecast is 63.52% higher than the current stock price, while the lowest is $11.07 (+43.21%) and the highest is $17.24 (+123.03%).
Price Target: $12.64 (+63.52%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jul 22, 2026.
Analyst Ratings
The average analyst rating for Medlive Technology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 4 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $12.00 | Buy | Maintains | $12.00 | +55.24% | Jul 22, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $17.00 | Buy | Maintains | $17.00 | +119.92% | Apr 13, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $11.40 | Buy | Maintains | $11.40 | +47.48% | Apr 2, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $10.90 | Buy | Maintains | $10.90 | +41.01% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
747.19M
from 642.16M
Increased by 16.36%
Revenue Next Year
877.23M
from 747.19M
Increased by 17.40%
EPS This Year
0.52
from 0.46
Increased by 11.97%
EPS Next Year
0.59
from 0.52
Increased by 13.94%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.